CT引导下经皮微波消融治疗肾细胞癌:评估肾肿瘤评分系统的性能
本研究回顾性纳入76例经活检证实的孤立性T1a(84%)或T1b(16%)肾细胞癌患者,均接受CT引导下微波消融,评估RENAL与mRENAL评分对肿瘤学结局的预测能力。结果显示RENAL与mRENAL评分最佳截断值均为6.5,进展风险在评分>6.5、T1b肿瘤、距集合系统<4 mm、跨极线及前壁位置患者中更高;消融不完全者两评分显著更高,ROC分析显示两评分对进展均有显著预测能力;并发症与上述因素均无关。
要点
- RENAL与mRENAL评分最佳截断值均为6.5,评分>6.5者进展风险更高。
- 进展率在肿瘤>4 cm、距集合系统<4 mm、跨极线及前壁位置时显著更高。
- 消融不完全者RENAL与mRENAL评分显著更高,并发症与上述因素无关。
核心结论
- RENAL与mRENAL评分>6.5、T1b肿瘤、距集合系统<4 mm、跨极线及前壁位置的患者进展风险更高;CT引导下经皮微波消融治疗T1a肾细胞癌安全有效。
研究设计与样本
- 机构数据库回顾性研究,纳入76例经活检证实的孤立性T1a(84%)或T1b(16%)肾细胞癌患者,均行CT引导下微波消融,计算RENAL与mRENAL评分。
关键影像表现/征象
- 多数病灶呈外生性(82.9%),距集合系统>7 mm者占53.9%,位于后壁者占73.6%,位于极线以下者占61.8%。
- RENAL评分均值5.7(标准差1.9),mRENAL评分均值6.1(标准差2.1)。
诊断标准与关键数值
- RENAL与mRENAL评分预测进展的最佳截断值均为6.5。
- 单因素Cox回归分析进展风险比:RENAL评分为7.73,mRENAL评分为7.48。
- ROC分析显示RENAL与mRENAL评分对进展均有显著预测能力,mRENAL评分的预测能力高于RENAL评分。
临床应用与阅片要点
- 阅片时可计算RENAL与mRENAL评分,评分>6.5提示微波消融后进展风险较高。
- 报告时应关注肿瘤大小>4 cm、距集合系统<4 mm、跨极线及前壁位置等形态学参数。
- 上述因素与并发症无关,并发症评估无需依据这些参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of the current study is to evaluate the performance of RENAL and mRENAL scores, in the prediction of oncological outcomes in patients treated with microwave ablation (MWA) for (T1) renal cell carcinomas (RCC).
METHODS: Institutional database retrospective research identified 76 patients with a biopsy-proven solitary T1a (84%) or T1b (16%) RCC; all patients underwent CT-guided MWA ablation. Tumor complexity was reviewed by calculating RENAL and mRENAL scores.
RESULTS: The majority of the lesions were exophytic (82.9%), with > 7 mm nearness to the collecting system (53.9%), located posteriorly (73.6%), and lower to polar lines (61.8%). Mean RENAL and mRENAL scores were 5.7 (SD = 1.9) and 6.1 (SD = 2.1) respectively. Progression rates were significantly higher with greater tumor size (> 4 cm), with < 4 mm nearness to the collecting system, for tumors crossing a polar line and with the anterior location. None of the above was associated with complications. RENAL and mRENAL scores were significantly higher in patients with incomplete ablation. The ROC analysis showed the significant prognostic ability of both RENAL and mRENAL scores for progression. In both scores, the optimal cut-off point was 6.5. Univariate Cox regression analysis for progression showed a hazard ratio of 7.73 for the RENAL score and 7.48 for the mRENAL score.
CONCLUSION: The results of the present study show that the risk of progression was higher in patients with RENAL and mRENAL score of > 6.5, in T1b tumors, close to the collective system (< 4 mm), crossing polar lines and anterior location.
CLINICAL RELEVANCE STATEMENT: CT-guided percutaneous MWA is a safe and effective technique for the treatment of T1a renal cell carcinomas. Different morphometric parameters of RCC tumors including RENAL and mRENAL score > 6.5, size, proximity to the collecting system, and crossing of polar lines impact the efficacy of MWA and progression survival rates.
KEY POINTS: • The risk of progression is higher in patients with RENAL and mRENAL score > 6.5, in T1b tumors, close to the collective system (< 4 mm), crossing polar lines and anterior location. • The significant prognostic ability of the mRENAL score for progression was higher than the respective of the RENAL score. • Complications were not associated with any of the above factors.
引用
- Efthymiou, Velonakis, Charalampopoulos, et al. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores. Eur Radiol. 2023. PMID: 37318604. doi:10.1007/s00330-023-09774-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。